Table 2 Readmission and length of stay of hospitalised individuals and associations adjusted with the variables sex, age group according to the presence of multimorbidity assessed as ≥ 2 or ≥ 3 chronic conditions. The Brazilian Longitudinal Study of Ageing (ELSI-Brazil), 2015–2016. (n = 887)
Multimorbidity ≥ 2 (n = 725) | ||||||
|---|---|---|---|---|---|---|
Independent variables | n | % (95%CI) | Readmission | Length of stay | ||
M (SD) | β (95%CI) | M (SD) | β (95%CI) | |||
Sex | ||||||
Female | 429 | 54,3 (49.0, 59.6) | 1.6 (1.1) | 1,00 | 4.9 (9.1) | 1,00 |
Male | 296 | 45,7 (40.4, 51.0) | 1.6 (1.3) | 0,04 (-0.27, 0.34) | 8.4 (11.0) | 3,56 (1.71, 5.42)* |
Age group | ||||||
50–59 | 245 | 38 (31.8, 44.6) | 1.6 (1.2) | 1,00 | 6.7 (10.9) | 1,00 |
60–74 | 310 | 42,3 (37.2, 47.6) | 1.6 (1.4) | -0,02 (-0.36, 0.33) | 6.1 (10.6) | -0,73 (-2.81, 1.35) |
≥ 75 | 170 | 19,7 (15.9, 24.0) | 1.4 (0.8) | -0,19 (-0.42, 0.04) | 6.8 (7.1) | 0,37 (-1.46, 2.19) |
Age group – Female | ||||||
50–59 | 140 | 38,7 (31.6, 46.4) | 1.7 (1.3) | 1,00 | 3.6 (4.9) | 1,00 |
60–74 | 180 | 38,5 (33.0, 44.3) | 1.5 (1.2) | -0,21 (-0.57, 0.15) | 5.2 (12.5) | 1,61 (-0.26, 3.47) |
≥ 75 | 109 | 22,8 (17.9, 28.5) | 1.4 (0.8) | -0,27 (-0.58, 0.03) | 6.3 (7.3) | 2,69 (1.1, 4.28)* |
Age group – Male | ||||||
50–59 | 105 | 37,2 (29.4, 45.6) | 1.5 (1.1) | 1,00 | 10.4 (14.5) | 1,00 |
60–74 | 130 | 46,8 (38.1, 55.8) | 1.7 (1.6) | 0,19 (-0.39, 0.78) | 7.0 (8.3) | -3,39 (-7.03, 0.24) |
≥ 75 | 61 | 16 (10.7, 23.1) | 1.4 (0.8) | -0,1 (-0.43, 0.24) | 7.5 (6.7) | -2,92 (-6.65, 0.82) |
Multimorbidity ≥ 3 (n = 572) | ||||||
Independent variables | n | % (95%CI) | Readmission | Length of stay | ||
M (SD) | β (95%CI) | M (SD) | β (95%CI) | |||
Sex | ||||||
Female | 357 | 58,4 (53.3, 63.3) | 1.6 (1.2) | 1,00 | 4.9 (9.5) | 1,00 |
Male | 215 | 41,6 (36.7, 46.7) | 1.7 (1.5) | 0,11 (-0.29, 0.51) | 7.9 (8.8) | 3,1 (1.61, 4.6)* |
Age group | ||||||
50–59 | 178 | 35,7 (29.2, 42.7) | 1.7 (1.3) | 1,00 | 5.8 (7.7) | 1,00 |
60–74 | 254 | 43,5 (37.9, 49.2) | 1.7 (1.5) | -0,01 (-0.44, 0.42) | 6.1 (11.2) | 0,03 (-1.79, 1.84) |
≥ 75 | 140 | 20,8 (17.1, 25.2) | 1.5 (0.8) | -0,24 (-0.54, 0.06) | 6.7 (7.5) | 1,04 (-0.61, 2.69) |
Age group – Female | ||||||
50–59 | 109 | 37 (29.7, 45.0) | 1.8 (1.3) | 1,00 | 3.7 (5.2) | 1,00 |
60–74 | 155 | 39,6 (33.8, 45.8) | 1.6 (1.2) | -0,2 (-0.66, 0.26) | 5.1 (13.0) | 1,37 (-0.61, 3.35) |
≥ 75 | 93 | 23,4 (18.5, 29.0) | 1.5 (0.8) | -0,28 (-0.69, 0.13) | 6.3 (7.6) | 2,54 (0.88, 4.2)* |
Age group – Male | ||||||
50–59 | 69 | 33,8 (25.4, 43.4) | 1.7 (1.2) | 1,00 | 9.1 (9.5) | 1,00 |
60–74 | 99 | 48,9 (38.8, 59.0) | 1.9 (1.8) | 0,25 (-0.52, 1.02) | 7.2 (8.7) | -1,86 (-4.82, 1.11) |
≥ 75 | 47 | 17,3 (11.5, 25.2) | 1.5 (0.9) | -0,19 (-0.64, 0.25) | 7.6 (7.3) | -1,49 (-4.56, 1.58) |